137 related articles for article (PubMed ID: 1377241)
1. Epitope mapping of HIV-1 reverse transcriptase with monoclonal antibodies that inhibit polymerase and RNase H activities.
Szilvay AM; Nornes S; Haugan IR; Olsen L; Prasad VR; Endresen C; Goff SP; Helland DE
J Acquir Immune Defic Syndr (1988); 1992; 5(7):647-57. PubMed ID: 1377241
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody-mediated inhibition of HIV-1 reverse transcriptase polymerase activity. Interaction with a possible deoxynucleoside triphosphate binding domain.
Wu J; Amandoron E; Li X; Wainberg MA; Parniak MA
J Biol Chem; 1993 May; 268(14):9980-5. PubMed ID: 7683687
[TBL] [Abstract][Full Text] [Related]
3. Characterization of HIV-1 reverse transcriptase with antibodies indicates conformational differences between the RNAse H domains of p 66 and p 15.
Szilvay AM; Nornes S; Kannapiran A; Haukanes BI; Endresen C; Helland DE
Arch Virol; 1993; 131(3-4):393-403. PubMed ID: 7688507
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies define linear and conformational epitopes of HIV-1 pol gene products.
Ferns RB; Partridge JC; Tisdale M; Hunt N; Tedder RS
AIDS Res Hum Retroviruses; 1991 Mar; 7(3):307-13. PubMed ID: 1712217
[TBL] [Abstract][Full Text] [Related]
5. Generation and characterization of murine monoclonal antibodies reactive against N-terminal and other regions of HIV-1 reverse transcriptase.
Li X; Amandoron E; Wainberg MA; Parniak MA
J Med Virol; 1993 Mar; 39(3):251-9. PubMed ID: 7682257
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone.
Borkow G; Fletcher RS; Barnard J; Arion D; Motakis D; Dmitrienko GI; Parniak MA
Biochemistry; 1997 Mar; 36(11):3179-85. PubMed ID: 9115994
[TBL] [Abstract][Full Text] [Related]
7. Structure-function relationships of HIV-1 reverse transcriptase determined using monoclonal antibodies.
Restle T; Pawlita M; Sczakiel G; Müller B; Goody RS
J Biol Chem; 1992 Jul; 267(21):14654-61. PubMed ID: 1378837
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of monoclonal antibodies raised against the reverse transcriptase of human immunodeficiency virus type 2 and cross-reactivity with that of type 1.
Snowden W; Coughlan N; Tisdale M; Stammers DK
J Acquir Immune Defic Syndr (1988); 1993 Nov; 6(11):1187-93. PubMed ID: 7693912
[TBL] [Abstract][Full Text] [Related]
9. Immunological characterization of the human immunodeficiency virus type 1 reverse transcriptase protein by the use of monoclonal antibodies.
Orvell C; Unge T; Bhikhabhai R; Bäckbro K; Rudén U; Strandberg B; Wahren B; Fenyö EM
J Gen Virol; 1991 Aug; 72 ( Pt 8)():1913-8. PubMed ID: 1714942
[TBL] [Abstract][Full Text] [Related]
10. Truncating alpha-helix E' of p66 human immunodeficiency virus reverse transcriptase modulates RNase H function and impairs DNA strand transfer.
Ghosh M; Howard KJ; Cameron CE; Benkovic SJ; Hughes SH; Le Grice SF
J Biol Chem; 1995 Mar; 270(13):7068-76. PubMed ID: 7535765
[TBL] [Abstract][Full Text] [Related]
11. Dissecting the effects of DNA polymerase and ribonuclease H inhibitor combinations on HIV-1 reverse-transcriptase activities.
Shaw-Reid CA; Feuston B; Munshi V; Getty K; Krueger J; Hazuda DJ; Parniak MA; Miller MD; Lewis D
Biochemistry; 2005 Feb; 44(5):1595-606. PubMed ID: 15683243
[TBL] [Abstract][Full Text] [Related]
12. An active recombinant p15 RNase H domain is functionally distinct from the RNase H domain associated with human immunodeficiency virus type 1 reverse transcriptase.
Evans DB; Fan N; Swaney SM; Tarpley WG; Sharma SK
J Biol Chem; 1994 Aug; 269(34):21741-7. PubMed ID: 7520442
[TBL] [Abstract][Full Text] [Related]
13. The ribonuclease H activity of HIV-1 reverse transcriptase: further biochemical characterization and search of inhibitors.
Andréola ML; Tharaud D; Litvak S; Tarrago-Litvak L
Biochimie; 1993; 75(1-2):127-34. PubMed ID: 7684932
[TBL] [Abstract][Full Text] [Related]
14. Mutations within the RNase H domain of human immunodeficiency virus type 1 reverse transcriptase abolish virus infectivity.
Tisdale M; Schulze T; Larder BA; Moelling K
J Gen Virol; 1991 Jan; 72 ( Pt 1)():59-66. PubMed ID: 1703563
[TBL] [Abstract][Full Text] [Related]
15. Mutagenesis of cysteine 280 of the reverse transcriptase of human immunodeficiency virus type-1: the effects on the ribonuclease H activity.
Sevilya Z; Loya S; Duvshani A; Adir N; Hizi A
J Mol Biol; 2003 Mar; 327(1):19-30. PubMed ID: 12614605
[TBL] [Abstract][Full Text] [Related]
16. Epitope mapping of the low-molecular-mass subunits of reverse transcriptase in human immunodeficiency virus type 1 by monoclonal antibodies.
Chandra P; Gerber T; Chandra A; Sarin PS; Pavlikov SP; Sidorovich I; Khaitov R; Ivanov V; Koziach A
Biomed Sci; 1990; 1(5):507-12. PubMed ID: 1723005
[TBL] [Abstract][Full Text] [Related]
17. The interaction of illimaquinone, a selective inhibitor of the RNase H activity, with the reverse transcriptases of human immunodeficiency and murine leukemia retroviruses.
Loya S; Hizi A
J Biol Chem; 1993 May; 268(13):9323-8. PubMed ID: 7683648
[TBL] [Abstract][Full Text] [Related]
18. The effects of cysteine mutations on the reverse transcriptases of human immunodeficiency virus types 1 and 2.
Hizi A; Shaharabany M; Tal R; Hughes SH
J Biol Chem; 1992 Jan; 267(2):1293-7. PubMed ID: 1370463
[TBL] [Abstract][Full Text] [Related]
19. Disruption of a salt bridge between Asp 488 and Lys 465 in HIV-1 reverse transcriptase alters its proteolytic processing and polymerase activity.
Goobar-Larsson L; Bäckbro K; Unge T; Bhikhabhai R; Vrang L; Zhang H; Orvell C; Strandberg B; Oberg B
Virology; 1993 Oct; 196(2):731-8. PubMed ID: 7690504
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the ribonuclease H activity of HIV-1 reverse transcriptase using RNA.DNA hybrid substrates derived from the gag region of HIV-1.
Mizrahi V
Biochemistry; 1989 Nov; 28(23):9088-94. PubMed ID: 2481501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
